Cargando…
Life-long tailoring of management for patients with hypertrophic cardiomyopathy: Awareness and decision-making in changing scenarios
Hypertrophic cardiomyopathy (HCM) is the most common genetic heart disease, characterised by complex pathophysiology and extensive genetic and clinical heterogeneity. In most patients, HCM is caused by mutations in cardiac sarcomere protein genes and inherited as an autosomal dominant trait. The cli...
Autores principales: | Michels, M., Olivotto, I., Asselbergs, F. W., van der Velden, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313451/ https://www.ncbi.nlm.nih.gov/pubmed/28005231 http://dx.doi.org/10.1007/s12471-016-0943-2 |
Ejemplares similares
-
Life-long tailoring of diagnosis and management of patients with idiopathic ventricular fibrillation—future perspectives in research
por: Blom, L. J., et al.
Publicado: (2018) -
Desmoplakin cardiomyopathy—an inherited cardiomyopathy presenting with recurrent episodes of acute myocardial injury
por: Schoonvelde, S. A. C., et al.
Publicado: (2022) -
Risk stratification and subclinical phenotyping of dilated and/or arrhythmogenic cardiomyopathy mutation-positive relatives: CVON eDETECT consortium
por: Roudijk, R. W., et al.
Publicado: (2021) -
Medical School, Cardiovascular Surgery, and Education: how we do it in Brazil’s scenario?
por: Ribeiro, Tiago Santos, et al.
Publicado: (2021) -
Artificial intelligence in cardiology: the debate continues
por: Asselbergs, Folkert W, et al.
Publicado: (2021)